Category: Medosis Newsroom

The U.S. Food and Drug Administration (FDA) has approved GlaxoSmithKline’s (GSK) BLENREP (belantamab mafodotin-blmf) on October 23, 2025, for the treatment…..

The U.S. Food and Drug Administration (FDA) has approved an expanded indication for Libtayo® (cemiplimab-rwlc) as an adjuvant treatment to prevent the…..

Researchers from University College London (UCL) and the University of Oxford have unveiled a groundbreaking ultrasound helmet system that can precisely……

The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast), a novel phosphodiesterase 4 (PDE4) inhibitor for the treatment of IPF…..

The U.S. Food and Drug Administration (FDA) has approved the first generic version of mifepristone (200 mg), developed by Evita Solutions, for the medical….